Pruritus clinical trials at UCSD
1 research study open to eligible people
Showing trials for
TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus
open to eligible people ages 18 years and up
This is a phase 2, randomized, open-label, single-center study that will assess the efficacy of TriCalm Hydrogel®, a topical gel containing strontium, for treating pruritus related to immune checkpoint inhibitors (ICIs).
La Jolla, California
Our lead scientists for Pruritus research studies include Karen M Yun, MD.
Last updated: